![]() |
|
|
Vol. 287, Issue 2, 640-647, November 1998
Department of Immunological Diseases, Research and Development
Center, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield,
Connecticut
We investigated the contractile effects of both activated and
unactivated polymorphonuclear leukocytes (PMNs) on human vascular tissue to characterize the influence of human PMNs on vascular tone.
PMNs were added either unactivated or after f-met-leu-phe (fMLP)
activation (10
8 M), into tissue chambers containing human
umbilical vein segments under either control or cytokine-treated
conditions. The activation state of different PMN preparations was
measured by immunofluorescence staining of the adhesion glycoproteins
Mac-1 and L-selectin. Both unactivated and activated PMNs induced a
cell number-dependent (1.5 × 105 to 2 × 106 cells/ml) vasoconstriction in human umbilical vein
segments. This PMN-induced response was not inhibited by treatment with indomethacin (10
5 M), superoxide dismutase (2 × 10
7 M) or L-nitro-monomethyl arginine
(10
4 M). However, treatment of PMNs with the leukotriene
biosynthesis inhibitor BIRM-270 partially inhibited (
61 ± 19%,
P < .05) the contraction induced only by unactivated PMNs.
Moreover, the supernatant from unactivated, but not that from
activated, PMNs elicited a contractile response comparable to that from
the addition of cells. We observed a significant correlation between
the Mac-1/L-selectin ratio of activated PMNs and the contractile
response they generated (r = 0.77, P < .05). The
activated PMN response had an endothelium-dependent component, whereas
the unactivated PMN response was endothelium-independent. These results
suggest that human PMNs of varying activation states have the capacity
to modulate vascular smooth muscle tone via distinct
mechanisms. Unactivated PMNs appear to modulate tone via a
secreted product, whereas the more activated phenotype modulates vascular tone via a cognate interaction with the endothelium.
This article has been cited by other articles:
![]() |
I. Berkestedt, A. Nelson, and M. Bodelsson Endogenous antimicrobial peptide LL-37 induces human vasodilatation Br. J. Anaesth., June 1, 2008; 100(6): 803 - 809. [Abstract] [Full Text] [PDF] |
||||